Our top pick for
NICE Ltd is a software-application business based in the US. NICE shares (NICE) are listed on the NASDAQ and all prices are listed in US Dollars. NICE employs 6,383 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$276.11|
|52-week range||$211.25 - $304.50|
|50-day moving average||$283.98|
|200-day moving average||$254.79|
|Wall St. target price||$325.90|
|Dividend yield||$0.16 (0.06%)|
|Earnings per share (TTM)||$3.05|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-0.30%|
|1 month (2021-09-21)||-0.78%|
|3 months (2021-07-21)||-0.20%|
|6 months (2021-04-21)||17.34%|
|1 year (2020-10-21)||21.39%|
|2 years (2019-10-21)||86.80%|
|3 years (2018-10-19)||157.54%|
|5 years (2016-10-21)||313.28%|
Valuing NICE stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NICE's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NICE's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 91x. In other words, NICE shares trade at around 91x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
NICE's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.2107. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NICE's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
NICE's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $432.7 million.
The EBITDA is a measure of a NICE's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.7 billion|
|Operating margin TTM||14.76%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||3.89%|
|Return on equity TTM||8.21%|
|Market capitalisation||$17.5 billion|
TTM: trailing 12 months
There are currently 1.7 million NICE shares held short by investors – that's known as NICE's "short interest". This figure is 0.3% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting NICE shares can be evaluated.
NICE's "short interest ratio" (SIR) is the quantity of NICE shares currently shorted divided by the average quantity of NICE shares traded daily (recently around 204358.69297164). NICE's SIR currently stands at 8.11. In other words for every 100,000 NICE shares traded daily on the market, roughly 8110 shares are currently held short.
However NICE's short interest can also be evaluated against the total number of NICE shares, or, against the total number of tradable NICE shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NICE's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 NICE shares in existence, roughly 30 shares are currently held short) or 0.0263% of the tradable shares (for every 100,000 tradable NICE shares, roughly 26 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against NICE.
Find out more about how you can short NICE stock.
We're not expecting NICE to pay a dividend over the next 12 months.
NICE's shares were split on a 2:1 basis on 30 May 2006. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your NICE shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for NICE shares which in turn could have impacted NICE's share price.
Over the last 12 months, NICE's shares have ranged in value from as little as $211.25 up to $304.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NICE's is 0.1693. This would suggest that NICE's shares are less volatile than average (for this exchange).
NICE Ltd. provides enterprise software solutions worldwide. The company operates in two segments, Customer Engagement, and Financial Crime and Compliance. It offers CXone, a cloud native open platform that supports contact centers ranging from small single sites to distributed remote agents and enterprises; and a digital-first omnichannel customer engagement platform that supports various digital and self-service channels, which allows organizations to add and integrate new and emerging channels. The company also provides AI driven smarter processes, agile workforce engagement, and customer experience management solutions. In addition, it offers NICE platform, a financial crime and compliance solution that handles various process, including detection, investigation, remediation, and reporting; and X-Sight, a cloud-based financial crime risk management platform-as-a-service. Further, the company provides professional service and support at various stages of the technology lifecycle, including defining requirements, planning, design, implementation, customization, optimization, maintenance, and ongoing support.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.